An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Seegers BA, Andriessen MP, van Hooijdonk CA, de Bakker ES, van Vlijmen-Willems IM, Parker GL, van Erp PE, van de Kerkhof PC.Seegers BA, et al. Among authors: van hooijdonk ca.Skin Pharmacol Appl Skin Physiol. 2000 Mar-Apr;13(2):75-85. doi: 10.1159/000029911.Skin Pharmacol Appl Skin Physiol. 2000.PMID: 10754455Clinical Trial.
Glade CP, van Erp PE, van Hooijdonk CA, Elbers ME, van de Kerkhof PC.Glade CP, et al. Among authors: van hooijdonk ca, van de kerkhof pc, van erp pe.Acta Derm Venereol. 1995 Sep;75(5):381-5. doi: 10.2340/0001555575381385.Acta Derm Venereol. 1995.PMID: 8615058Free article.Clinical Trial.
van Pelt JP, de Jong EM, van Erp PE, Mitchell MI, Marder P, Spaethe SM, van Hooijdonk CA, Kuijpers AL, van de Kerkhof PC.van Pelt JP, et al. Among authors: van hooijdonk ca, van de kerkhof pc, van erp pe.Biochem Pharmacol. 1997 Apr 4;53(7):1005-12. doi: 10.1016/s0006-2952(96)00884-2.Biochem Pharmacol. 1997.PMID: 9174114Free article.Clinical Trial.
Van Pelt JP, De Jong EM, Seijger MM, Van Hooijdonk CA, De Bakker ES, Van Vlijmen IM, Parker GL, Van Erp PE, Van De Kerkhof PC.Van Pelt JP, et al. Among authors: van hooijdonk ca.Br J Dermatol. 1998 Sep;139(3):396-402. doi: 10.1046/j.1365-2133.1998.02401.x.Br J Dermatol. 1998.PMID: 9767282Clinical Trial.
van Rossum MM, Mommers JM, van Hooijdonk CA, van Erp PE, van de Kerkhof PC.van Rossum MM, et al. Among authors: van hooijdonk ca.Skin Pharmacol Appl Skin Physiol. 1999 Sep-Oct;12(5):271-5. doi: 10.1159/000066252.Skin Pharmacol Appl Skin Physiol. 1999.PMID: 10461096Clinical Trial.
Smit JV, de Jong EM, van Hooijdonk CA, Otero ME, Boezeman JB, van de Kerkhof PC.Smit JV, et al. Among authors: van hooijdonk ca.J Am Acad Dermatol. 2004 Aug;51(2):257-64. doi: 10.1016/j.jaad.2004.03.002.J Am Acad Dermatol. 2004.PMID: 15280845Clinical Trial.
Arnold WP, van Hooijdonk CA, Mier PD, van de Kerkhof PC.Arnold WP, et al. Among authors: van hooijdonk ca, van de kerkhof pc.Br J Dermatol. 1990 Nov;123(5):581-5. doi: 10.1111/j.1365-2133.1990.tb01474.x.Br J Dermatol. 1990.PMID: 2248887
Glade CP, Seegers BA, Meulen EF, van Hooijdonk CA, van Erp PE, van de Kerkhof PC.Glade CP, et al. Among authors: van hooijdonk ca, van de kerkhof pc, van erp pe.Arch Dermatol Res. 1996 Apr;288(4):203-10. doi: 10.1007/BF02505225.Arch Dermatol Res. 1996.PMID: 8967793Free article.
van Hooijdonk CA, van Erp PE, Freund RL, de Jongh GJ, Schalkwijk J, van de Kerkhof PC, Mier PD.van Hooijdonk CA, et al. Among authors: van de kerkhof pc, van erp pe.Cell Prolif. 1993 Nov;26(6):567-76. doi: 10.1111/j.1365-2184.1993.tb00034.x.Cell Prolif. 1993.PMID: 9116123
Mommers JM, Castelijns FA, Seegers BA, Van Rossum MM, Van Hooijdonk CA, Van Erp PE, Van De Kerkhof PC.Mommers JM, et al. Among authors: van hooijdonk ca.Br J Dermatol. 1998 Sep;139(3):468-71. doi: 10.1046/j.1365-2133.1998.02411.x.Br J Dermatol. 1998.PMID: 9767292Clinical Trial.